Cell Growth & Differentiation, Vol 8, Issue 7 743-749, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors

CK Derian, AJ Eckardt and P Andrade-Gordon
R.W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477-0776, USA.

Thrombin receptor (ThrR) and protease-activated receptor-2 (PAR-2) are members of a unique G protein-coupled receptor family, which are characterized by the unveiling of a tethered peptide ligand upon proteolysis of their NH2 terminus. We have previously shown that cultured human basal keratinocytes express both receptors (R.J. Santulli et al., Proc. Natl. Acad. Sci. USA, 92: 9151-9155, 1995); however, their functional role in epidermal physiology has yet to be described. In the present study, we determined the effects of receptor activation on keratinocyte cell growth and differentiation using thrombin (selective for ThrR), SLIGRL (selective for PAR-2), and SFLLRN (stimulates ThrR and PAR-2), as agonists. ThrR stimulation enhanced cell growth in a dose-dependent manner in the absence of growth factors (epidermal growth factor and bovine pituitary extract). In contrast, under the same conditions, activation of PAR-2 led to the inhibition of cell growth. This inhibitory activity by PAR-2 activation was also observed in the presence of growth factors. Activation of both receptors diminished protein expression of the differentiation marker transglutaminase type 1 induced by either calcium or IFN-gamma. Calcium-induced involucrin expression was also decreased. These results indicate that PAR-2 and ThrR differentially modulate keratinocyte function and may provide an important regulatory function in the epidermis by altering the functional state of keratinocytes.

This article has been cited by other articles:

				M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response Endocr. Rev., February 1, 2005; 26(1): 1 - 43. [Abstract] [Full Text] [PDF]

				E. Bitoun, A. Micheloni, L. Lamant, C. Bonnart, A. Tartaglia-Polcini, C. Cobbold, T. Al Saati, F. Mariotti, J. Mazereeuw-Hautier, F. Boralevi, et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome Hum. Mol. Genet., October 1, 2003; 12(19): 2417 - 2430. [Abstract] [Full Text] [PDF]

				R. Lang, P. I. Song, F. J. Legat, R. M. Lavker, B. Harten, H. Kalden, E. F. Grady, N. W. Bunnett, C. A. Armstrong, and J. C. Ansel Human Corneal Epithelial Cells Express Functional PAR-1 and PAR-2 Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 99 - 105. [Abstract] [Full Text] [PDF]

				L. S. Chambers, J. L. Black, P. Poronnik, and P. R. A. Johnson Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1369 - L1378. [Abstract] [Full Text] [PDF]

				S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]

				E. Sharlow, C. Paine, L Babiarz, M Eisinger, S Shapiro, and M Seiberg The protease-activated receptor-2 upregulates keratinocyte phagocytosis J. Cell Sci., January 9, 2000; 113(17): 3093 - 3101. [Abstract] [PDF]

				I. A. Akers, M. Parsons, M. R. Hill, M. D. Hollenberg, S. Sanjar, G. J. Laurent, and R. J. McAnulty Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2 Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L193 - L201. [Abstract] [Full Text] [PDF]

				B. P. Damiano, W.-M. Cheung, R. J. Santulli, W.-P. Fung-Leung, K. Ngo, R. D. Ye, A. L. Darrow, C. K. Derian, L. de Garavilla, and P. Andrade-Gordon Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1 J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 671 - 678. [Abstract] [Full Text]

				O. Dery, C. U. Corvera, M. Steinhoff, and N. W. Bunnett Proteinase-activated receptors: novel mechanisms of signaling by serine proteases Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1429 - C1452. [Abstract] [Full Text] [PDF]

				M. R. D'Andrea, C. K. Derian, D. Leturcq, S. M. Baker, A. Brunmark, P. Ling, A. L. Darrow, R. J. Santulli, L. F. Brass, and P. Andrade-Gordon Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues J. Histochem. Cytochem., February 1, 1998; 46(2): 157 - 164. [Abstract] [Full Text]